Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 48601-48650 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT04462458
M-ARS ACL Post-marketing Surveillance Study
N/A
Recruiting
200 participants
Started: Jul 1, 2022 · Completed: Jan 31, 2027
1 condition
1 sponsor
3 locations
NCT06063005
Clinical Study of Translocated Internal Limiting Membrane Flap Reposition for the Treatment of Idiopathic Macular Hole
NA
Recruiting
76 participants
Started: Jul 1, 2022 · Completed: Jun 30, 2025
1 condition
2 sponsors
1 location
NCT05411744
One-month Latent Tuberculosis Treatment for Renal Transplant Candidates
PHASE4
Recruiting
25 participants
Started: Jul 1, 2022 · Completed: Jun 30, 2029
4 conditions
1 sponsor
1 location
NCT05428137
Study of Safety and Efficacy of a Probiotic and Postbiotic in Overweight Individuals
NA
Recruiting
180 participants
Started: Jul 1, 2022 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT05597709
Prevalence of MAFLD in Patients With Type 2 Diabetes in Jiangsu Province of China
N/A
Recruiting
2,900 participants
Started: Jul 1, 2022 · Completed: Jun 1, 2027
2 conditions
12 sponsors
1 location
NCT04565795
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
NA
Recruiting
87 participants
Started: Jul 1, 2022 · Completed: Sep 30, 2026
1 condition
2 sponsors
4 locations
NCT05230758
Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour
PHASE3
Recruiting
140 participants
Started: Jul 1, 2022 · Completed: Jun 30, 2027
2 conditions
1 sponsor
19 locations
NCT05663788
Web-based Learning Module on Optical Diagnosis of Early Colorectal Cancer
NA
Recruiting
166 participants
Started: Jul 1, 2022 · Completed: Mar 31, 2024
2 conditions
4 sponsors
12 locations
NCT05306145
Comparison of H-FIRE and TURP in Treating Benign Prostatic Hyperplasia
NA
Recruiting
118 participants
Started: Jun 30, 2022 · Completed: Apr 1, 2026
1 condition
1 sponsor
1 location
NCT05399433
Role of Glucose Metabolism in Migration of Cutaneous Dendritic Cells in Psoriasis
NA
Recruiting
100 participants
Started: Jun 30, 2022 · Completed: Sep 1, 2026
1 condition
1 sponsor
1 location
NCT05420779
A Study to Evaluate the Efficacy and Safety of TSL-1502 Capsules in Breast Cancer Patients With Germline BRCA Mutations
PHASE2
Recruiting
125 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05040178
An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and Pediatrics
N/A
Recruiting
20 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2032
3 conditions
2 sponsors
5 locations
NCT05208879
CArotenoid in hypoChOlesterolemia
N/A
Recruiting
40 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
3 conditions
1 sponsor
3 locations
NCT05788614
Retroversion in Reverse Shoulder Arthroplasty
NA
Recruiting
90 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05437315
GD2/PSMA Bi-specific CAR-T Cell Therapy
PHASE1/PHASE2
Recruiting
60 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05483816
MultiSENSory Stimulation to TArgeT Sensory Loss and ChronIc Pain in NeurOpathic PatieNts
NA
Recruiting
40 participants
Started: Jun 30, 2022 · Completed: Feb 28, 2028
5 conditions
2 sponsors
1 location
NCT05437341
PSMA/CD70 Bi-specific CAR-T Cell Therapy
PHASE1/PHASE2
Recruiting
60 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05353322
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
NA
Recruiting
324 participants
Started: Jun 30, 2022 · Completed: Mar 31, 2026
4 conditions
2 sponsors
1 location
NCT05736146
Validating Gulf War Illness Blood Biomarkers
N/A
Recruiting
100 participants
Started: Jun 30, 2022 · Completed: Mar 1, 2026
2 conditions
4 sponsors
3 locations
NCT05513755
Cardioneuroablation in Reflex Syncope (CARDIOSYRE Trial)
NA
Recruiting
92 participants
Started: Jun 30, 2022 · Completed: Dec 31, 2025
1 condition
18 sponsors
1 location
NCT04991116
Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis
PHASE3
Recruiting
650 participants
Started: Jun 30, 2022 · Completed: Apr 30, 2029
1 condition
1 sponsor
97 locations
NCT05350332
Effects of Lung Volume on Upper Airway Patency During Drug Induced Sleep Endoscopy
NA
Recruiting
200 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition
2 sponsors
1 location
NCT05037305
VICE-MPRINT: Maternal and Pediatric Pharmacogenetics Survey
NA
Recruiting
500 participants
Started: Jun 30, 2022 · Completed: Oct 30, 2025
1 condition
1 sponsor
2 locations
NCT04042844
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
PHASE2
Recruiting
99 participants
Started: Jun 30, 2022 · Completed: Dec 31, 2027
1 condition
1 sponsor
19 locations
NCT05076682
Reverse Triple Negative Immune Resistant Breast Cancer
PHASE2
Recruiting
70 participants
Started: Jun 30, 2022 · Completed: Mar 31, 2027
1 condition
1 sponsor
1 location
NCT06088576
Using a Digital Application for Adolescents in Dropout of Care in Mental Health : Facilitate the Return in Classic Care With Telepsychiatry, Tchats, Forums and a Home Medical Team.
NA
Recruiting
50 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT05418088
Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies
PHASE1
Recruiting
54 participants
Started: Jun 30, 2022 · Completed: Jul 31, 2026
18 conditions
2 sponsors
2 locations
NCT05244551
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK061 in Patients With Advanced Solid Tumors
PHASE1
Recruiting
85 participants
Started: Jun 30, 2022 · Completed: Apr 30, 2025
1 condition
1 sponsor
22 locations
NCT05437328
GD2/CD56 Bi-specific CAR-T Cell Therapy
PHASE1/PHASE2
Recruiting
60 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05576818
Effect of Synbiotic as an Adjuvant Therapy in the Treatment of Parkinson's Disease
PHASE3
Recruiting
66 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT05338619
A Study of Lazertinib as Consolidation Therapy in Patients With Locally Advanced, Unresectable, EGFR-Mutant Non-Small Cell Lung Cancer (Stage III) Following Chemoradiation Therapy
PHASE2
Recruiting
77 participants
Started: Jun 30, 2022 · Completed: Mar 2, 2026
3 conditions
2 sponsors
13 locations
NCT05303064
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
PHASE3
Recruiting
220 participants
Started: Jun 30, 2022 · Completed: Sep 30, 2026
2 conditions
1 sponsor
47 locations
NCT04990713
QoR40 Between Intercostal Block and Intercostal Block and Serratus Plane Catheter During VATS
NA
Recruiting
200 participants
Started: Jun 30, 2022 · Completed: Jan 31, 2026
2 conditions
1 sponsor
1 location
NCT04648280
Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their cART and Have Dual- or Triple-class Antiretroviral Resistance
PHASE1/PHASE2
Recruiting
60 participants
Started: Jun 30, 2022 · Completed: Sep 30, 2028
1 condition
5 sponsors
10 locations
NCT05309993
INvestigation of TENS Efficacy Versus Posterior Tibial Nerve Stimulation for Overactive Bladder
NA
Recruiting
130 participants
Started: Jun 30, 2022 · Completed: Dec 31, 2026
5 conditions
1 sponsor
1 location
NCT05436496
CD19/70 Bi-specific CAR-T Cell Therapy
PHASE1/PHASE2
Recruiting
30 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05438368
GD2/CD70 Bi-specific CAR-T Cell Therapy
PHASE1/PHASE2
Recruiting
30 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05163288
A Pivotal Study of N-Acetyl-L-Leucine on Niemann-Pick Disease Type C
PHASE3
Recruiting
53 participants
Started: Jun 30, 2022 · Completed: Dec 31, 2028
1 condition
1 sponsor
14 locations
NCT05364827
CT Coronary Angiography Prior to CTO PCI
NA
Recruiting
20 participants
Started: Jun 30, 2022 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT05432882
CD19/22 Bi-specific CAR-T Cell Therapy
PHASE1/PHASE2
Recruiting
60 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05436509
CD19/79b Bi-specific CAR-T Cell Therapy
PHASE1/PHASE2
Recruiting
60 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05223894
Treating Heart Failure With hiPSC-CMs
PHASE1/PHASE2
Recruiting
20 participants
Started: Jun 30, 2022 · Completed: Dec 30, 2025
1 condition
2 sponsors
1 location
NCT05726526
CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients
NA
Recruiting
340 participants
Started: Jun 30, 2022 · Completed: Mar 30, 2026
2 conditions
1 sponsor
5 locations
NCT05206838
Achilles Tendon for the Treatment of Gluteus Medius Insufficiency
NA
Recruiting
44 participants
Started: Jun 29, 2022 · Completed: Dec 31, 2028
4 conditions
4 sponsors
1 location
NCT05141682
Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia
PHASE1/PHASE2
Recruiting
27 participants
Started: Jun 29, 2022 · Completed: Jan 31, 2026
1 condition
2 sponsors
2 locations
NCT05401357
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
PHASE3
Recruiting
168 participants
Started: Jun 29, 2022 · Completed: Dec 31, 2022
2 conditions
2 sponsors
9 locations
NCT05566275
Remote Cognitive Assessment for Surgical Patients
N/A
Recruiting
30 participants
Started: Jun 29, 2022 · Completed: Dec 31, 2023
2 conditions
2 sponsors
1 location
NCT04814446
Nonavalent HPV Vaccine in the Treatment of Difficult-to-treat Palmo-plantar Warts
PHASE3
Recruiting
146 participants
Started: Jun 29, 2022 · Completed: Jun 29, 2026
1 condition
1 sponsor
1 location
NCT05218850
The Use of Butyrate Therapy in Pediatric Ulcerative Colitis
PHASE1
Recruiting
10 participants
Started: Jun 29, 2022 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT06156891
PD-1 Inhibitor Based Induction Chemotherapy Followed by De-escalation Protocols in OPSCC
PHASE2
Recruiting
60 participants
Started: Jun 29, 2022 · Completed: Jul 30, 2025
1 condition
1 sponsor
1 location
Previous
1
More pages
970
971
972
973
974
975
976
More pages
1333
Next